Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

10:29 AM ET 8-K
Business Update Rci Hospitality Holdings, Inc. RICK

Rci Hospitality Holdings Business Update

RCI Hospitality reported preliminary sales for its nightclubs and sports bar-restaurants for the fourth fiscal quarter and full year ended September 30, 2026. Combined sales for the quarter rose 0.8% to $70.4 million, driven by an 18.3% increase in the Bombshells segment, while full-year combined sales grew 2.0% to $282.2 million.

Term
4Q26
10:22 AM ET 8-K
Loan & Debt Centene Corp CNC

Centene $569M Debt Financing with The Bank of New York Mellon Trust Company, N.A.

Centene Corporation has issued a notice to redeem the remaining $568.664 million aggregate principal amount of its 4.25% Senior Notes due 2027. The redemption is scheduled for October 23, 2026, at a price of 100% of the principal plus accrued interest, after which no 2027 Notes will remain outstanding.

Value
$569M
Counterparty
The Bank of New York Mellon Trust Company, N.A.
10:20 AM ET 8-K
Loan & Debt JLL Income Property Trust, Inc. ZIPTAX

JLL Income Property Trust $68.5M Debt Financing

JLL Income Property Trust closed a $68.5 million mortgage loan secured by the Whitestown Distribution Center IV, a 1.1 million-square-foot industrial facility in Indianapolis. The loan carries a seven-year term with a fixed interest rate of 5.54% and is intended to enhance point forward returns through disciplined leverage.

Value
$68.5M
Term
7 years
9:47 AM ET 8-K
Loan & Debt Federal Home Loan Bank of Dallas

Federal Home Loan Bank of Dallas $40M Debt Financing with Office of Finance

The Federal Home Loan Bank of Dallas committed to the issuance of $40 million in consolidated obligation bonds. The issuance consists of two tranches: a $10 million bond maturing in 2036 and a $30 million bond maturing in 2056, both featuring optional principal redemption terms.

Value
$40M
Counterparty
Office of Finance
Term
through Oct 2056
9:36 AM ET 8-K
Business Update Msc Income Fund, Inc. MSIF

Msc Income Fund Business Update

MSC Income Fund announced its private loan portfolio activity for Q3 2026, originating $62.2 million in new or increased commitments and funding $61.4 million in investments. As of September 30, 2026, the Fund's private loan portfolio totaled approximately $849.6 million at cost across 81 unique companies, with 90.1% of the portfolio consisting of first lien senior secured debt.

Term
Q3 2026
9:30 AM ET 8-K
Business Update Main Street Capital Corp MAIN

Main Street Capital Business Update

Main Street Capital Corporation announced its private loan portfolio activity for the third quarter of 2026, originating $157.2 million in new or increased commitments and funding $162.0 million in total investments. As of September 30, 2026, the company's private loan portfolio reached approximately $2.1 billion at cost across 86 unique companies, with 92.6% of the portfolio consisting of first lien senior secured debt.

Term
Q3 2026
9:25 AM ET 8-K
M&A Deal Pacira BioSciences, Inc. PCRX

Pacira BioSciences Signs $1.65B M&A Deal with Viatris Inc.

Pacira BioSciences entered into a definitive agreement to be acquired by Viatris Inc. for $36.50 per share in cash, representing an aggregate equity value of approximately $1.65 billion. The transaction will be executed via a cash tender offer and is expected to close by the end of 2026, positioning Viatris as a leader in non-opioid pain therapies.

Value
$1.65B
Counterparty
Viatris Inc.
9:16 AM ET 8-K
Reverse Stock Split Blue Star Foods Corp. BSFC

Blue Star Foods Reverse Stock Split

Blue Star Foods Corp. implemented a 1-for-1,600 reverse stock split of its issued and outstanding common stock, effective October 8, 2026. The split reduces the company's outstanding shares from approximately 171.9 million to approximately 107,488 shares. The action was taken to consolidate shares while maintaining the authorized share count at 5 billion common shares.

9:14 AM ET 8-K
M&A Deal Charlton Aria Acquisition Corp CHAR

Charlton Aria Acquisition M&A Deal with KQC Quantum, Inc.

Charlton Aria Acquisition Corp (SPAC) has entered into a definitive business combination agreement with KQC Quantum, Inc., a quantum computing and security company. The filing includes an investor presentation and webcast script detailing the transaction, which will result in KQC Quantum becoming a publicly traded entity. The deal aims to accelerate KQC's commercialization of quantum technology across the finance, industrial, and public sectors.

Counterparty
KQC Quantum, Inc.
9:01 AM ET 8-K
Leadership Change Rb Global Inc. RBA

Rb Global Leadership Change

RB Global appointed Steve Steinberg as Chief Financial Officer, effective October 7, 2026, succeeding Eric Guerin. The company also announced several other executive promotions, including Shiv Dutt to Chief Digital and Strategy Officer, Jake Lawson to President of HE&T North America, and Sam Wyant to President of Auto North America and International.

Earnings call
Nov 9, 2026, 8:30 AM ET
9:00 AM ET 8-K
Contract Win Hallador Energy Co HNRG

Hallador Energy Wins $693M Contract from Duke Energy Indiana, LLC

Hallador Energy's subsidiary entered into a six-year Power Purchase Agreement and a capacity credit agreement with Duke Energy Indiana for electricity from the Merom Generating Station. The combined agreements are expected to generate approximately $693 million in revenue ($271 million from capacity credits and an estimated $422 million from energy sales) through 2035. This deal increases Hallador's total forward sales book to $3 billion and secures approximately 95% of the station's accredited capacity through 2035.

Value
$693M
Counterparty
Duke Energy Indiana, LLC
Term
6 years (June 1, 2029 through May 31, 2035)
8:42 AM ET 8-K
Divestiture Global Arena Holding, Inc. GAHC

Global Arena Holding Divestiture to GES Acquisition Corp. for $1.42M

Global Arena Holding and its subsidiary Global Election Services entered into an amended asset purchase agreement to sell their technology-enabled election services business to GES Acquisition Corp. The consideration includes $1.42 million in cash, the issuance of 1,841,761 shares of the buyer's common stock, and the forgiveness of approximately $3.63 million in previously funded debt and interest.

Value
$1.42M
Counterparty
GES Acquisition Corp.
8:41 AM ET 8-K
Business Update Beyond Air, Inc. XAIR

Beyond Air Business Update

Beyond Air preannounced preliminary unaudited revenue of $2.3 million for the quarter ended September 30, 2026, representing 30% sequential growth. The company also reaffirmed its full-year revenue guidance for 2026 and 2027 while noting its second-generation LungFit PH system remains under FDA review.

8:39 AM ET 8-K
Regulatory Approval Vir Biotechnology, Inc. VIR

Vir Biotechnology Regulatory Approval

Vir Biotechnology announced that the FDA has granted Fast Track designation to VIR-5500, a PSMA-targeted T-cell engager being co-developed with Astellas Pharma for the treatment of metastatic castration-resistant prostate cancer. The designation is intended to expedite the development and review of the drug, which is currently in Phase 1 trials with Phase 3 development anticipated to begin in 2027.

Counterparty
Astellas Pharma Inc.
8:38 AM ET 8-K
M&A Deal Viatris Inc VTRS

Viatris Signs $1.65B M&A Deal with Pacira BioSciences, Inc.

Viatris Inc. has entered into a definitive agreement to acquire Pacira BioSciences for $36.50 per share in cash, representing an aggregate equity value of approximately $1.65 billion. The acquisition adds two marketed non-opioid pain therapies, EXPAREL and ZILRETTA, to Viatris' portfolio and is expected to close by the end of 2026.

Value
$1.65B
Counterparty
Pacira BioSciences, Inc.
8:31 AM ET 8-K
Other 8-K Filing bioAffinity Technologies, Inc. BIAF

bioAffinity Technologies Other 8-K Filing

bioAffinity Technologies received a Notice of Allowance from the Japan Patent Office for a patent covering its CyPath Lung test, a noninvasive diagnostic for early-stage lung cancer. This marks the company's first AI-algorithm-related patent in Japan and its fifth patent in the Asian market. The patent protects the company's proprietary method of using automated flow cytometry and machine learning to predict lung cancer likelihood.

Counterparty
Japan Patent Office
8:30 AM ET 8-K
Business Update Powercompute, Inc. PWCM

Powercompute Business Update

PowerCompute reported its September 2026 operational update, mining 8.1 Bitcoin and generating $89,000 from energy sales during curtailment periods. The company also completed the repayment of a $22.45 million Bitcoin-backed credit facility using 267.4 BTC, significantly reducing its total secured debt to $1.25 million.

Term
September 2026
8:30 AM ET 8-K
Leadership Change Change Agents Corporation. CHGA

Change Agents Leadership Change

Meng Li has resigned from her roles as Interim CEO, COO, and Secretary of Change Agents Corporation, effective October 8, 2026. Her departure is intended to facilitate the company's preparation for a potential acquisition in the drone defense industry, and the Board has initiated a search for a replacement from the global defense and AI sectors.

8:30 AM ET 8-K
Other 8-K Filing Nn Inc NNBR

Nn Other 8-K Filing

NN, Inc. redeemed all 18,400 remaining outstanding shares of its Series D Perpetual Preferred Stock for approximately $30.7 million, effectively eliminating the security from its balance sheet. The redemption was funded by proceeds from a recent PIPE transaction and included a $5.0 million incentive reduction from the holder. As a result of the final redemption, the holder's rights, including board observer rights, have been terminated.

Counterparty
NHTV Nevada Holdings LP
8:22 AM ET 8-K
Other 8-K Filing Innventure, Inc. INV

Innventure Other 8-K Filing

Innventure, Inc. has established a new at-the-market (ATM) equity offering program with a maximum capacity of $60 million and concurrently discontinued its existing standby equity purchase agreement (SEPA) with YA II PN, Ltd. The company intends to use the ATM program for flexible, disciplined capital management to support its operations and the development of its subsidiary, Accelsius.

8:20 AM ET 8-K
Investor Presentation Mission Produce, Inc. AVO

Mission Produce Investor Presentation

Mission Produce is hosting its 2026 Investor Day to unveil a five-year growth strategy targeting mid-single-digit organic sales growth and 300 basis points of margin expansion. The company also introduced a long-term 2035 ambition to double sales and triple Adjusted EBITDA while providing an update on its $100 million stock repurchase program.

Term
5 years

“Mission was built to lead. Over more than 40 years, we built the modern avocado category and created a platform that would be difficult to replicate. Our next chapter is about fully leveraging that platform and compounding the value we deliver to shareholders by growing faster than our markets, expanding margins, converting more earnings into cash and deploying that cash with discipline.”

John Pawlowski, President and Chief Executive Officer
8:10 AM ET 8-K
Financial Results Byrna Technologies Inc. BYRN

Byrna Technologies Financial Results

Byrna Technologies reported fiscal third quarter 2026 net revenue of $15.3 million, a 46% decrease from the prior year due to lower e-commerce sales and slower dealer reorders. The company reported a net loss of $2.9 million compared to net income of $2.2 million in the same period last year, though gross margins improved to 79% (65% adjusted) driven by manufacturing efficiencies and a one-time tariff refund.

Term
Q3 2026
Earnings call
Oct 8, 2026, 9:00 AM ET

“While our third quarter revenue reflects a challenging comparison to last year's significant channel restocking, we are encouraged by the structural improvements in our business model. Our successful transition to outsourced ammunition production and the expansion of our adjusted gross margins demonstrate our commitment to operational efficiency and long-term profitability as we continue to scale the Byrna brand through new influencer and media partnerships.”

Bryan Ganz, CEO of Byrna Technologies
8:04 AM ET 8-K
Other 8-K Filing Aquabounty Technologies Inc AQB

Aquabounty Technologies Other 8-K Filing

AquaBounty Technologies entered into agreements with holders of its Series A and Series B Preferred Stock to automatically convert all outstanding preferred shares into approximately 8.08 million shares of common stock. The conversion is expected to occur by October 30, 2026, at which point the preferred shares will be cancelled and retired. The company has also agreed to file a registration statement to facilitate the resale of these newly issued common shares.

8:01 AM ET 8-K
Business Update NextTrip, Inc. NTRP

NextTrip Business Update

NextTrip reported initial global viewing metrics for its JOURNY TV platform, generating over 307 million viewing minutes from January through August 2026. Following an advertising operations transition in July 2026, the company saw a 668% increase in average monthly Samsung U.S. programmatic advertising revenue and projects full-year 2026 revenue for that segment to nearly double year-over-year.

Counterparty
Samsung
Term
Jan-Aug 2026
8:01 AM ET 8-K
Reverse Stock Split Dragonfly Energy Holdings Corp. DFLI

Dragonfly Energy Holdings Reverse Stock Split

Dragonfly Energy Holdings Corp. has announced a 1-for-8 reverse stock split of its common stock, effective October 12, 2026. The split is intended to increase the bid price of the company's shares to regain compliance with Nasdaq's $1.00 minimum bid price requirement. No fractional shares will be issued; instead, stockholders will receive one whole share in lieu of any fractional interest.

8:01 AM ET 8-K
Financial Results Novagold Resources Inc NG

Novagold Resources Financial Results

NOVAGOLD reported a net loss of $36.0 million, or $0.08 per share, for the third fiscal quarter ended August 31, 2026. The company maintained a strong treasury with $343.4 million in cash and term deposits to fund the ongoing Bankable Feasibility Study for the Donlin Gold project. Results were impacted by elevated professional fees related to the pending acquisition of Paulson's 40% interest in Donlin Gold.

Term
Q3 2026
Earnings call
Oct 8, 2026, 11:00 AM ET
7:44 AM ET 8-K
M&A Deal DiamondRock Hospitality Co DRH

DiamondRock Hospitality Signs $31M M&A Deal with The Bellmoor Inn & Spa

DiamondRock Hospitality Company completed the acquisition of The Bellmoor Inn & Spa, a 79-room luxury resort in Rehoboth Beach, Delaware, for $31.0 million. The acquisition price represents a 10.4x Hotel EBITDA multiple and an 8.6% capitalization rate based on trailing twelve-month results. The company plans to implement asset management initiatives and off-season capital improvements to reach a projected stabilized NOI yield of 9.5%.

Value
$31M
Counterparty
The Bellmoor Inn & Spa
7:41 AM ET 8-K
Business Update Hyperfine, Inc. HYPR

Hyperfine Business Update

Hyperfine reported preliminary unaudited third quarter 2026 revenue of approximately $6.0 million, representing 53% sequential growth. The company also reported estimated cash and cash equivalents of $37.9 million and reaffirmed its full-year 2026 revenue guidance of $20 million to $22 million.

7:30 AM ET 8-K
Stock Buyback Virginia National Bankshares Corp VABK

Virginia National Bankshares Announces $18.7M Stock Buyback

Virginia National Bankshares Corporation has authorized a new share repurchase plan to buy back up to $18.7 million of its common stock. The program is authorized to run through October 5, 2027, and allows for repurchases in the open market or through private transactions. This plan signals management's commitment to returning capital to shareholders based on market conditions and corporate needs.

Value
$18.7M
Term
through Oct 5, 2027
7:18 AM ET 8-K
Financial Results Angiodynamics Inc ANGO

Angiodynamics Financial Results

AngioDynamics reported fiscal first quarter 2027 net sales of $80.9 million, representing 6.9% year-over-year growth driven by its Med Tech segment. The company achieved a GAAP gross margin of 59.4% and an adjusted EBITDA of $5.0 million. Additionally, the company announced that Eric Honroth will succeed Jim Clemmer as President and CEO effective November 2, 2026.

Term
Q1 2027

“Our first quarter results reflect the continued, consistent execution we’ve built into this business. Med Tech again led our growth, highlighted by Auryon’s 21st consecutive quarter of double-digit atherectomy growth, continued performance in Mechanical Thrombectomy, and ongoing strength in our NanoKnife oncology platform.”

Jim Clemmer, President and Chief Executive Officer

“As I shared previously, after ten years leading this company, I have decided to retire, and the Board has completed a comprehensive search for my successor. I’m pleased to share that Eric Honroth will become our next President and Chief Executive Officer.”

Jim Clemmer, President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.